We report the cloning of a Leishmania chagasi antigen gene and an evaluation of leishmaniasis patient antibody responses to the recombinant protein, rK39. rK39 contains a 39-amino acid repeat that is part of a 230-kDa protein predominant in L. chagasi tissue amastigotes. Sequence analyses showed this protein, LcKin, to be related to the kinesin superfamily of motor proteins. Southern blot analyses demonstrated LcKin-related sequences in seven species of Leishmania, with conservation of the repeat between L. chagasi and Leishmania donovani. Serological evaluation revealed that 98% (56 of 57) of Brazilian and 100% (52 of 52) of Sudanese visceral leishmaniasis patients have high antibody levels to the rK39 repeat. Detectable anti-K39 antibody was virtually absent in cutaneous and mucosal leishmaniasis patients and in individuals infected with Trypanosoma cruzi. The data show that rK39 may replace crude parasite antigens as a basis for serological diagnosis of visceral leishmaniasis.
Protozoan parasites of the genus Leishmania are widely distributed and transmitted by the bite of sandflies. In the vertebrate host, the infecting promastigotes differentiate into and replicate as amastigotes within macrophages. Symptoms range from self-healing skin lesions to diffuse cutaneous and mucosal manifestations, or severe visceral involvement of the spleen, liver, and lymph nodes. Visceral leishmaniasis (VL) is generally caused by Leishmania donovani in Africa, India, and southern Europe or Leishmania chagasi in Latin America. In VL, high antibody levels are observed prior to the detection of parasite-specific T-cell responses (1) . This antibody response has been exploited for the diagnosis of L. chagasi and L. donovani infection (2) (3) (4) (5) . The current World Health Organization's estimate of 12 million cases of leishmaniasis and recent epidemics of VL in Sudan and India (6, 7) highlight the need for more effective control measures. Diagnostic tests use whole or lysed Leishmania, and a few studies have begun to examine patient antibody responses to specific antigens (2, (8) (9) (10) . Such studies may improve diagnostic assays and help to evaluate B-cell responses during disease progression.
We report the cloning and expression of an L. chagasi gene sequence "I and an evaluation of patient antibody responses to the recombinant product, rK39. The sequence encodes an immunodominant protein with a repetitive epitope closely conserved between L. chagasi and L. donovani. This repeat is part of a large kinesin-related protein expressed predominantly by amastigotes. More than 98% of Brazilian and 100% of Sudanese VL patients had readily detectable serum antibody responses to the K39 repeat. Philadelphia) , and Trypanosoma cruzi (MHOM/CH/00/ Tulahuen C2) were used. Promastigotes and epimastigotes were cultured in axenic media. L. chagasi and L. amazonensis amastigotes were obtained from spleens of Syrian hamsters and footpads of BALB/cByJ mice, respectively, and purified as described (11) .
MATERIALS AND METHODS
Patient Sera. Brazilian leishmaniasis sera and T. cruzi infection sera were from well-characterized patients in Bahia, Brazil; Sudanese leishmaniasis sera were from Leishmaniapositive patients; normal sera were from healthy individuals in Sudan or the United States (2, 4, 12) .
Identification and Purification of rK39. A genomic library was constructed with sheared DNA of L. chagasi (MHOM/ BR/82/BA-2,C1) in Lambda ZAPII (Stratagene) and screened with preadsorbed serum (13) of a L. donovani patient. The 39-kDa recombinant antigen of clone K39 (rK39) was purified from a 25-40o ammonium sulfate fraction of bacterial lysate by preparative isoelectric focusing (IEF) with the Rotofor IEF cell and 1% 3/10 ampholytes (pH range 3.5-9.5; Bio-Rad) in the presence of 8 M urea and 10 mM dithiothreitol. Peak fractions were concentrated by ammonium sulfate precipitation and dialyzed against 25 mM Tris'HCI, pH 8/150 mM NaCl (TBS). Protein concentrations were determined by using the Pierce BCA assay, and purity was assessed by Coomassie blue-staining following SDS/ PAGE (14) .
Immunoblot Analysis. Immunoblots of parasite lysates or purified rK39 were prepared (11) . Filters were blocked with TBS containing 5% nonfat dried milk and probed with patient sera (1:250 dilution) or rabbit sera (1:400 dilution) diluted in TBS containing 0.1% Tween-20 and 1% bovine serum albuAbbreviation: VL, visceral leishmaniasis.
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Parasite DNAs were isolated, digested with Pst I, separated by agarose gel electrophoresis, and analyzed by Southem blotting (13) . Blots were probed with a 2.4-kilobase (kb) HindIII fragment of LcKin derived from the 5' end of the gene (probe A) or the 915-base-pair (bp) insert of clone K39 (probe B). Probes were radiolabeled with [a-32PldCTP to a specific activity of 9 x 108 cpm/,ug of DNA by using random oligonucleotide primers (Boehringer Mannheim). Final washes were for 1 hr in 0.015 M NaCl/0.0015 M sodium citrate, pH 7/0.5% SDS at 68°C. Blots of L. chagasi DNA digested with BamHI, HindIII, and Pst I were prepared and probed as above. Probe A contained one BamHI, one Pst I, and no HindIlI sites. Probe B did not contain sites for these enzymes.
K39 Antigen ELISA. rK39 or L. chagasi promastigote lysate was diluted in coating buffer (15 mM Na2HCO3/28 mM NaH2CO3, pH 9.6), and microassay plates (Probind; Falcon) were sensitized overnight at 4°C with rK39 (50 ng) or promastigote lysate (1 ug) followed by blocking with phosphatebuffered saline (PBS) containing 1% Tween-20 for 1 hr at room temperature. After five washes with PBS containing 0.1% Tween-20 (PBS-T), 50 ,ul per well of sera diluted 1:100 with PBS-T were incubated for 30 min at room temperature. Wells were washed five times with PBS-T, and bound antibody was detected by protein A-conjugated horseradish peroxidase (Zymed Laboratories) as described (2) . Absorbance values are relative to the mean of five control sera assayed on each plate.
RESULTS
Identification of L. chagasi Antigen Genes. To characterize Leishmania antigens recognized by VL patients, a L. chagasi expression library was screened with sera from a L. donovani patient. From =32,000 recombinants, 7 clones were selected that contained inserts of 0.9-2.6 kb and produced immunoreactive recombinant proteins of 35-100 kDa. The recombinant antigen of clone K39 (rK39) was exceptionally reactive with test serum. rK39 migrated as a 39-kDa protein in induced bacterial extracts (Fig. 1 Proc. Natl. Acad. Sci. USA 90 (1993) iCAGCTTCGC6AATCC6AGGAGCGCGCTGC66A6CT66CGA6CCA6CT66AG6CCACTGCTGCTGC6MGTCGTC66CG6tiACAGGACC6C6A6AACACGA66CCACGCTA6A6CAGCAGCTTCGCGA 2700 q l r e s e e r a a e L a s q Le a t a a a ks s a ae 9 d r e n t r a t l e q L l r e iCTGGCGAGCCAGCTGGAGGCCACTGCT6CTGCGAAGATGTCAGCGG6CAGGACCGC6AGAACAC6A666CCACGCTA6AGCAGCAGCTTC6T6ACTCC6A66AGC6CGCTGC66AGCTG6C6A6CCA 2850 750 s e a r a a e L a s a l e a t a a a k a s a e a d r e n t r a t l e a a L r d a e e r a a e l a s a 6CT66AGTCCACTACTGCTGCGAAGATGTCAGCGGAGCA6MACC6C66A6CACGA66GCCACGCTA6A6CA6CA6CTTCGTGACTCC6A666GCGCGCT6C666GCT66C6A6CCAGCTGGA6TCCACTACTGCTGC6AA6ATGTCAGC 3000 800 L e s t t a a k * 3 (Fig. SA, lanes 3-9) (Fig. SB, lanes 3-9) . The K39 repeat appeared most closely related between L. chagasi and L. donovani (Fig. 5B, lanes 3 and 7) . No hybridization with either probe was observed with T. cruzi DNA (Fig. 5, lane 10) .
When using L. chagasi digested DNA, two Pst I fragments were detected, with probe B indicating the presence of a second copy of the LcKin gene or polymorphism in restriction sites present in the 3' repetitive sequences (Fig. 5B, lane  3) . Probe A hybridized to three fragments in each of the BamHI, HindIII, and Pst I digests of L. chagasi DNA (Fig.  SA, lanes 1-3) Identification of the Native LcKin Antigen. Rabbit anti-rK39 serum was used to probe SDS/PAGE blots of L. chagasi promastigote and tissue amastigote lysates. The antiserum bound specifically to purified rK39 (Fig. 6A, lane 2) and to an -230-kDa L. chagasi antigen present in amastigotes (Fig. 6B , lane 6) and to a lesser degree in promastigotes (Fig. 6B, lane  5) . No reactivity with this serum was detected in promastigote and amastigote lysates of L. amazonensis (Fig. 6B, lanes  7-8) . . .
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as shown by the reactivity ofa rabbit antiserum raised against a constitutively expressed L. chagasi ribosomal phosphoprotein, LcPO (Fig. 6C) (24) .
Reactivity of Patient Sera with rK39. The reactivity of patient sera with rK39 was evaluated by ELISA. Among VL patients, 98.2% of Brazilian sera (56 of 57) and 10%/o of Sudanese sera (52 of 52) were positive on rK39 (absorbance values were >3 standard deviations above the mean of normal controls). Values ranged from 0.05 to >2.0 (mean = 1.38) among Brazilian VL sera and from 0.094 to >2.0 (mean = 1.60) among Sudanese VL sera (Fig. 7B) . Detectable antibody to rK39 was restricted to VL patients, as little or no anti-rK39 response was observed in mucosal or cutaneous leishmaniasis sera or T. cruzi infection sera, despite reactivity with crude L. chagasi lysate (Fig. 7A) (25) . These microtubule-based motors are involved in such varied intracellular processes as organelle and synaptic vescicle transport, chromosome segregation, and spindle pole body separation, nuclear fusion, protein sorting, and flagellar beating (25, 26 A striking feature of LcKin was the high prevalence of antibody to the K39 repeat in VL patients from geographically distinct regions. This response was restricted to VL patients, reflecting the relatedness among members of the L. donovani complex (27) (28) (29) . The characterization of patient B-cell responses to defined Leishmania antigens has been minimal (2, (8) (9) (10) . Our studies are unique in showing VLrestricted antibody responses to a recombinant antigen of L. chagasi and showing a marked restriction of this response to L. chagasi-and L. donovani-infected patients.
Repetitive amino acid domains have been observed in many parasitic protozoan antigens, often being immunodominant B-cell epitopes that detect high levels of antibody in infected patients (16, (30) (31) (32) (33) (34) . It is unclear if such responses contribute to the development of protective immunity or are immunological "smokescreens" limiting the development of protective responses (30, 35) . In preliminary studies, 10 of 25 asymptomatic or subclinical patients infected with L. chagasi had elevated levels of anti-K39 antibody (unpublished data). As only 30-35% of such individuals develop acute VL (36), the fate of those with a positive anti-K39 titer may be informative. Such prospective studies should help to determine whether the anti-K39 response is associated with the progression or resolution of VL. Nevertheless, from a practical standpoint, the data presented here as well as data from field studies in epidemic regions of VL in Sudan (H.W.G., W.G.S., D.R.B., J.M.B., S.G.R., unpublished data) show that rK39 may be useful in the serological diagnosis of acute VL.
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